FDA Approves Inhalable Insulin Drug, Afrezza

June 30, 2014 7:02 PM

15 0

The U.S. Food and Drug Administration (FDA) has approved MannKind Corp.'s inhalable insulin drug Afrezza.

The decision will allow diabetics to use inhalers instead of needles to control insulin levels, writes Nature World News.

Also read: FDA approves Gilead's drug for chronic hep C patients

Read more

To category page